CY1107921T1 - Μεθοδος για την προγνωση της αθροιστικης επιβιωσης ασθενων - Google Patents

Μεθοδος για την προγνωση της αθροιστικης επιβιωσης ασθενων

Info

Publication number
CY1107921T1
CY1107921T1 CY20081100395T CY081100395T CY1107921T1 CY 1107921 T1 CY1107921 T1 CY 1107921T1 CY 20081100395 T CY20081100395 T CY 20081100395T CY 081100395 T CY081100395 T CY 081100395T CY 1107921 T1 CY1107921 T1 CY 1107921T1
Authority
CY
Cyprus
Prior art keywords
prediction
patient survival
survival patients
patients
progression
Prior art date
Application number
CY20081100395T
Other languages
English (en)
Inventor
Rainer H Prof Dr BÖGER
Original Assignee
Germed Iq Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7653206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1107921(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Germed Iq Gmbh filed Critical Germed Iq Gmbh
Publication of CY1107921T1 publication Critical patent/CY1107921T1/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Μέθοδος και μέσα για την ανίχνευση μίας πιθανότητας της μελλοντικής εμφάνισης ή της προόδου παθήσεων, οι οποίες εξελίσσονται με μία διαταραχή του μεταβολισμού του NO, χαρακτηριζόμενη από το γεγονός, ότι διαπιστώνεται μία περιεκτικότητα σε ενδογενείς μεθυλο-αργινίνες σε ένα βιολογικό υγρό.
CY20081100395T 2000-08-18 2008-04-11 Μεθοδος για την προγνωση της αθροιστικης επιβιωσης ασθενων CY1107921T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040904A DE10040904A1 (de) 2000-08-18 2000-08-18 Verfahren und Mittel zum Nachweis einer Wahrscheinlichkeit zukünftigen Fortschreitens von Gefässerkrankungen
EP01967000A EP1354205B1 (de) 2000-08-18 2001-08-11 Verfahren zur prognose des kumulativen überlebens von patienten

Publications (1)

Publication Number Publication Date
CY1107921T1 true CY1107921T1 (el) 2013-09-04

Family

ID=7653206

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100395T CY1107921T1 (el) 2000-08-18 2008-04-11 Μεθοδος για την προγνωση της αθροιστικης επιβιωσης ασθενων

Country Status (9)

Country Link
EP (1) EP1354205B1 (el)
AT (1) ATE384266T1 (el)
AU (1) AU2001287533A1 (el)
CY (1) CY1107921T1 (el)
DE (2) DE10040904A1 (el)
DK (1) DK1354205T3 (el)
ES (1) ES2322548T3 (el)
PT (1) PT1354205E (el)
WO (1) WO2002014873A2 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0308967D0 (en) * 2003-04-17 2003-05-28 Univ London Screen for pre-eclampsia
LT2313364T (lt) 2008-08-07 2021-01-25 Idexx Laboratories, Inc. Simetrinio dimetilarginino nustatymo būdai
CA2923140C (en) 2013-09-05 2023-09-26 Idexx Laboratories, Inc. Methods for detecting renal disease
CN113699125A (zh) 2015-02-20 2021-11-26 艾德克斯实验室公司 带有对背景信号的补偿的均相免疫测定
US11422136B2 (en) 2017-10-19 2022-08-23 Idexx Laboratories, Inc. Detection of symmetrical dimethylarginine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7269098A (en) * 1997-05-01 1998-11-24 Cooke Pharma, Inc. Cardiovascular disease risk assessment
US6358699B1 (en) * 1999-02-05 2002-03-19 Cooke Pharma Assay for asymmetrical NG, NG dimethyl-l-arginine

Also Published As

Publication number Publication date
WO2002014873A3 (de) 2003-08-07
DE10040904A1 (de) 2002-02-28
EP1354205B1 (de) 2008-01-16
ATE384266T1 (de) 2008-02-15
ES2322548T3 (es) 2009-06-23
PT1354205E (pt) 2008-04-21
AU2001287533A1 (en) 2002-02-25
DK1354205T3 (da) 2008-05-13
EP1354205A2 (de) 2003-10-22
WO2002014873A2 (de) 2002-02-21
DE50113517D1 (de) 2008-03-06

Similar Documents

Publication Publication Date Title
CY1108397T1 (el) Αντι-ccr4 αντισωμα και θραυσμα αυτου
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
ATE479383T1 (de) Ph-sensor
EA200600452A1 (ru) Автоматизированные способы и системы для обнаружения и анализа сосудистых бляшек
HK1070575A1 (en) Use of botulinum toxin for treating cardiovasculardiseases
EA200801071A1 (ru) Способы и композиции для применения в целях лечения пациентов с положительным по аутоантителам заболеванием
BR0316969A (pt) Tratamento de mal de huntington com epa
WO2002018652A3 (en) Method for detection of htr and htert telomerase-associated rna in plasma or serum
NO20052220L (no) Fremgangsmater for behandling av Alzheimers sykdom ved anvendelse av antistoffer rettet mot amyloid beta-peptid og preparater derav
CY1107921T1 (el) Μεθοδος για την προγνωση της αθροιστικης επιβιωσης ασθενων
DK1327143T3 (da) Krystalstruktur af BACE og anvendelse deraf
UA99094C2 (ru) Способ лечения пациента с системной красной волчанкой
BRPI0517976A (pt) métodos de tratamento
ATE356994T1 (de) Screeningverfahren mit pim1-kinase oder pim3- kinase
ATE382383T1 (de) Apherese-vorrichtung
YU68602A (sh) Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje
EP1804789A4 (en) METHOD FOR TREATING PREECLAMPSY IN HUMANS WITH RESIBUFAGENIN
NO984197D0 (no) Fremgangsmåte for behandling av autisme
ATE546548T1 (de) Verfahren zur prognose des nutzens einer antioxidationshemmenden therapie zur vorbeugung von herz-kreislauf-erkrankungen bei hyperglykämischen patienten
DE50007816D1 (de) Verfahren zur auffindung von nukleotidsyntheseinhibitoren mit weniger nebenwirkungen
UA40839A (uk) Спосіб визначення ступеня сприйняття психологічного впливу у осіб чоловічої статі шляхом психохарактерологічного тестування
WO2004004643A3 (en) Interferon gamma in the detection and treatment of angiomyolipomas
MD2322G2 (ro) Metodă de micşorare a hipertensiunii arteriale, induse de supraactivitatea sistemului renin-angitensin-aldosteron
UA28113C2 (uk) Спосіб експрес-тестування ефективності реабілітації здоров'я людини
UA34212A (uk) Спосіб оцінки результатів лікування хворих на ранні форми сифілісу